Streamlining electrospun shellac coatings on paper for high moisture strength and barrier food packaging film: Tailoring the processing parameters for accelerated coating.

Coated paper with bio-based components has sparked attention as a food packaging alternative to plastic. This study focusses on development of environmentally friendly packaging solution by electrospraying shellac over paper's surface. The goal of the study is to reduce the time of fabrication, by optimising the process parameters, concentration; 20, 30, and 40%w/v, flow rate; 10, 20, and 30 ml/h, and coating time; 100, 200, and 300 s (Concentration (% w/v))/ Flow rate (ml/h)/ time (sec)), in order to get better GSM (grams per square meter), COBB (grams of water absorbed per square meter), KIT (oil resistance ability), and WVTR (water vapor transmission rate).

Synergistic Effect of HAD-B1 and Osimertinib Against Gefitinib Resistant HCC827 Non-Small Cell Lung Cancer Cells.

In this study, we investigated the synergistic effect of co-administration of osimertinib and HAD-B1 using gefitinib-resistant non-small cell lung cancer cells, HCC827-GR. HAD-B1 is composed of 4 natural drugs, Panax Notoginseng Radix, Panax ginseng C. A.

Hierarchical Selenium-Doped Nickel-Cobalt Hybrids on Carbon Paper for the Overall Water-Splitting Electrocatalytic System.

Designing and constructing hierarchically structured materials with heterogeneous compositions is the key to developing an effective catalyst for overall water-splitting applications. Herein, we report the fabrication of hollow-structured selenium-doped nickel-cobalt hybrids on carbon paper as a self-supported electrode (denoted as Se-Ni|Co/CP, where Ni|Co hybrids consist of nickel-cobalt alloy-incorporated nickel-cobalt oxide). The procedure involves direct growth of zeolitic imidazolate framework-67 (ZIF-67) on bimetal-based nickel-cobalt hydroxide (NiCoOH) electrodeposited on CP, followed by selenous etching and pyrolysis to obtain the final Se-Ni|Co/CP electrocatalytic system.

Predictive impact of clinical factors on chemosensitivity in advanced high-grade serous ovarian carcinoma according to chemotherapy response score.

The use of neoadjuvant chemotherapy (NAC) as a first-line therapy for advanced high-grade serous ovarian carcinoma (HGSOC) has increased. However, several studies have reported NAC-induced platinum resistance. This study aimed to evaluate the predictive impact of clinical factors on chemotherapy response score (CRS) and to select patients who would respond well to NAC.